Omeros Corporation
NASDAQ:OMERBiotechnology
+$0.43 today
- Market cap
- $1.08B
- Beta
- 2.53
- P/E (TTM)
- 8.4
- EPS (TTM)
- $1.20
Volume 2.53M
Average 1.55M
OMER Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Omeros CorporationNASDAQ: OMER
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q1 FY2026 depreciation & amortization of $239K fell 17.3% year over year, ahead of the -227.7% change in trailing-twelve-month depreciation & amortization. Over 3 fiscal years it compounded at +0.4% a year.
Context
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -17.3% holds above the trailing-twelve-month pace of -227.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 964K USD
- Year-over-year change
- +1.5%
- 4-year CAGR
- -8.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 964K | +1.5% |
| FY2024 | 2024-12-31 | 950K | +3.3% |
| FY2023 | 2023-12-31 | 920K | -3.4% |
| FY2022 | 2022-12-31 | 952K | -31.3% |
| FY2021 | 2021-12-31 | 1.39M | — |
Depreciation & Amortization vs competitors
How OMER compares with its peers on the latest reported figures
- OMER's LTM Mar 2026 depreciation & amortization of $1.32M is the 6th largest of the 11 companies compared; the peer median is $1.8M.
- Its year-over-year change of -227.7% is the lowest of 10, against a peer median of +1.2%.
- Depreciation & amortization amounts to 13.4% of revenue for OMER, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $10.32M | +18.9% | +92.7% | — | |
| LTM Jun 2026 | $10.17M | -10.7% | +6.1% | 9.7% | |
| LTM Jun 2026 | $10M | +0.0% | +18.6% | 8.5% | |
| LTM Mar 2026 | $6.94M | -7.1% | -22.5% | 4.4% | |
| LTM Mar 2026 | $2.43M | +1.2% | +1.2% | 1.0% | |
| LTM Mar 2026 | $1.32M | -227.7% | +0.4% | 13.4% | |
| LTM Mar 2026 | $1.18M | +9.0% | -11.2% | 236.0% | |
| LTM Mar 2026 | $314K | +2.6% | +49.5% | — | |
| LTM Jun 2026 | $129K | -88.2% | — | 0.2% | |
| LTM Mar 2026 | $112K | +33.3% | -34.1% | — | |
| LTM Dec 2025 | $0 | — | -0.5% | 0.0% | |
| Peer median (excluding OMER) | $1.8M | +1.2% | +1.2% | 4.4% | |
Competitors are the stored peer set for OMER. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (191.55M) | (182.03M) | (117.81M) | (156.82M) | (3.35M) |
| Depreciation & Amortization | 1.39M | 952K | 920K | 950K | 964K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 11.65M | 10.49M | 8.19M |
| Change in Working Capital | (14.11M) | (118.97M) | 247.42M | 29.74M | 33.72M |
| Accounts Receivables | (34.31M) | (175.07M) | 245.72M | 40.01M | 30.45M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 14.64M | (10.67M) | 0 | 0 | 0 |
| Other Working Capital | 5.57M | 66.76M | 1.7M | (10.27M) | 3.27M |
| Other Non-Cash Items | 94.54M | 213.56M | (67.46M) | (33.17M) | (155.62M) |
| Operating Cash Flow | (109.72M) | (86.48M) | 74.73M | (148.8M) | (116.09M) |
| Capital Expenditures | (277K) | (113K) | (426K) | (165K) | (65K) |
| Acquisitions (Net) | 125.99M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (32.01M) | (429.05M) | (1.02B) | (987.39M) | (185.31M) |
| Sales of Investments | 100M | 301.59M | 1.05B | 1.07B | 109.9M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 240M |
| Investing Cash Flow | 193.71M | (127.56M) | 27.45M | 82.22M | 164.52M |
| Debt Repayment | (1.82M) | 123.83M | (101.58M) | (41.34M) | (89.16M) |
| Common Stock Issued | 8.38M | 415K | 0 | 0 | 46.99M |
| Common Stock Repurchased | 0 | 0 | (4.65M) | (11.85M) | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (241K) | 0 | 150K | 116.07M | 0 |
| Financing Cash Flow | 6.32M | 124.25M | (106.08M) | 62.88M | (42.17M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 90.31M | (89.8M) | (3.9M) | (3.71M) | 6.26M |
| Free Cash Flow | (110M) | (86.6M) | 74.3M | (148.97M) | (116.16M) |
Omeros Corporation
NASDAQ:OMER
Intrinsic Alpha fair value
Locked
Current Price
$14.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.